Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Progressive Metastatic Castrate Resistant Prostate Cancer × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Xerostomia Due to Radiotherapy (Disorder) 1 Ulcer 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Seizures 1 Renal Insufficiency 1 Progressive Metastatic Castrate Resistant Prostate Cancer 1 Kidney Failure, Chronic 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Carcinoma, Renal Cell 1 COVID-19 1 Breast Neoplasms 1 Advanced/Metastatic Solid Tumors 1 2019 Novel Coronavirus 1

Interventions

Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07206056 2026-03-02

TulmiSTAR-01

Novartis

Phase 1/2 Recruiting

Progressive Metastatic Castrate Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡